Pharmacoeconomic analysis of Xeloda (capecitabine) in combination with docetaxel for the treatment of advanced breast cancer pretreated with anthracyclines.

被引：0
|
作者：
O'Shaughnessy, JA
Jones, SE
Vukelja, SJ
Kaywin, PR
Kroener, JF
Maraninchi, D
Moore, MR
Jamieson, C
Hornberger, J
机构：
[1] US Oncol, Dallas, TX USA
[2] Onc Hem Grp S Florida, Miami, FL USA
[3] Scripps Clin, La Jolla, CA USA
[4] Inst J Paoli I Calmettes, F-13009 Marseille, France
[5] Georgia Canc Specialists, Decatur, GA USA
[6] Roche Pharmaceut, Palo Alto, CA USA
[7] Stanford Univ, Stanford, CA 94305 USA
[8] Baylor Sammons Canc Ctr, Houston, TX USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
264
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [1] Population-based pharmacoeconomic model for adopting capecitabine/docetaxel combination treatment for anthracycline-pretreated metastatic breast cancer
    Verma, S
    Ilersich, AL
    [J]. ONCOLOGIST, 2003, 8 (03): : 232 - 240
  • [2] Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines
    D C Talbot
    V Moiseyenko
    S Van Belle
    S M O'Reilly
    E Alba Conejo
    S Ackland
    P Eisenberg
    D Melnychuk
    T Pienkowski
    H-U Burger
    S Laws
    B Osterwalder
    [J]. British Journal of Cancer, 2002, 86 : 1367 - 1372
  • [3] Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines
    Talbot, DC
    Moiseyenko, V
    Van Belle, S
    O'Reilly, SM
    Conejo, EA
    Ackland, S
    Eisenberg, P
    Melnychuk, D
    Pienkowski, T
    Burger, HU
    Laws, S
    Osterwalder, B
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (09) : 1367 - 1372
  • [4] Xeloda (capecitabine) plus docetaxel combination therapy in locally advanced/metastatic breast cancer: latest results.
    Vukelja, SJ
    Moiseyenko, V
    Leonard, R
    Conte, PF
    Garin, A
    McKendrick, J
    Possinger, K
    Turpin, FL
    Vandenberg, TA
    O'Shaughnessy, JA
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 269 - 269
  • [5] Capecitabine and docetaxel combination for the treatment of breast cancer
    Morishita, Mariko
    Leonard, Robert C.
    [J]. WOMENS HEALTH, 2008, 4 (01) : 11 - 22
  • [6] Docetaxel-gemcitabine in patients with HER2-negative metastatic breast cancer pretreated with anthracyclines.
    Bautista Aragon, Y. L.
    Pluma Jimenez, M. A.
    Silva, A. J.
    Perez, M.
    Gutierrez, J. A.
    Villalobos, R.
    Rivera, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer
    Nabholtz, JM
    North, S
    Smylie, M
    Mackey, J
    Au, HJ
    Au, R
    Morrish, D
    Salter, E
    Tonkin, K
    [J]. SEMINARS IN ONCOLOGY, 2000, 27 (02) : 11 - 18
  • [8] Australian economic analysis of Xeloda (capecitabine) in combination with docetaxel for the treatment of patients with advanced breast cancer after failure of prior anthracycline-containing chemotherapy.
    Todd, CJ
    Malanos, G
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S136 - S136
  • [9] Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and/or Taxanes
    Yao, Guangyu
    Cao, Li
    Liu, Mingfeng
    Chen, Lujia
    Hu, Xiaolei
    Ye, Changsheng
    [J]. CHEMOTHERAPY, 2015, 61 (04) : 171 - 178
  • [10] Bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
    Schmid, P
    Schippinger, V
    Kiewe, P
    Lange, W
    Preiss, J
    Niederle, N
    Brossart, P
    Freier, W
    Van de Velde, H
    Possinger, K
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S68 - S69
12345